
Pulse Economics is a specialist market access consultancy.
Accelerating Access.
Enhancing Value.
ORGANISATIONS WE’VE WORKED WITH











Struggling with Market Access?
The Challenge You Face
- Complex market access and reimbursement pathways across PBS, MBS and Prescribed List
- Uncertainty around clinical, economic and value evidence requirements
- Evolving PBAC, MSAC and MDHTAC expectations and increasing scrutiny

How Pulse Economics Solves It
- Faster progression to funding on the PBS, MBS and Prescribed List with fewer avoidable rework cycles
- Clinical, economic and pricing evidence built to withstand HTA and payer scrutiny
- Decision-ready market access strategies aligned to PBAC, MSAC and MDHTAC
- End-to-end submission support from strategy through to acceptance

WE PROVIDE
Evidence Strategy & Generation
Design and support clinical and real-world evidence strategies that directly address HTA, payer and policy requirements.
Market Access & Reimbursement
Guide clients through the complexities of PBS, MBS and Prescribed List pathways, helping products progress efficiently from evidence generation to reimbursement and patient access.
Commercialisation & Growth Strategy
Developing robust commercialisation strategies for startups and established players, supporting growth and effective life cycle management.
Modelling & Data Analytics
Perform robust statistical, financial and economic modelling that withstand HTA and payer scrutiny.
Health Policy
Support government, research organisations and industry in shaping health policy initiatives.
Most Popular Articles
5 Common Mistakes Sponsors Make in MSAC Submissions for Diagnostic and Investigative Technologies
For sponsors seeking public reimbursement in Australia, submissions for diagnostic and investigative technologies present a fundamentally different challenge to therapeutic…
Market Access Discussion Forum: PBAC IO Broad Listing Case Study
Attend our Market Access Discussion Forum tailored for professionals in the pharmaceutical industry! This event provides a unique platform to…
Pulse Economics joins national Advanced Therapies Advisory Group
Pulse Economics is pleased to share that Oona Reardon, Managing Director, has been appointed as a member of the newly established Medicines…




